Hi, I have a simple question about the CRISPR Dual-Knockout (CDKO) screening in the DepMap portal.
In this paper, the authors mentioned that ‘DepMap also consists of drug-gene and gene-gene combinatorial CRISPR screens’ in the Method and Materials section and specify the number of those cases (71,691) in the Result.
But to my knowledge, there was no data about the CDKO targeting the two genes simultaneously.
Did I miss such a dataset? Or did the authors describe the wrong data?
If anyone knows about this dataset in this portal, please let me know.
Thank you for reading this question.
1 post - 1 participant